FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)

NCT ID: NCT06111586

The FABULINUS trial is studying a new treatment called frexalimab for people with Type 1 Diabetes Mellitus (T1D) who are already using insulin. The goal of the trial is to see if frexalimab can hel...

Recruiting

Phase: PHASE2 Conditions: Type 1 Diabetes Mellitus

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma

NCT ID: NCT06091254

This clinical trial is studying a new experimental drug called odronextamab to see if it is safe and effective for people with follicular lymphoma, a type of blood cancer. The trial has two parts: ...

Recruiting

Phase: PHASE3 Conditions: Follicular Lymphoma (FL)

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

NCT ID: NCT05939414

This clinical trial is studying a new treatment called lutetium (177Lu) vipivotide tetraxetan for men with oligometastatic prostate cancer (OMPC), which means their cancer has spread to a few place...

Recruiting

Phase: PHASE3 Conditions: Oligometastatic Prostate Cancer (OMPC)

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

NCT ID: NCT06216301

The LUNAR-2 clinical trial is examining a new treatment approach for patients with metastatic non-small cell lung cancer (NSCLC), which is cancer that has spread from the lungs to other parts of th...

Recruiting

Phase: PHASE3 Conditions: Metastatic Non-small Cell Lung Cancer

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

NCT ID: NCT06393374

This clinical trial is studying a new treatment for patients with triple-negative breast cancer (TNBC) who did not completely respond to earlier treatment before surgery. The researchers want to fi...

Recruiting

Phase: PHASE3 Conditions: Triple-Negative Breast Cancer

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

NCT ID: NCT06141473

This clinical trial is studying the effectiveness and safety of a medication called frexalimab (also known as SAR441344) for adults who have relapsing forms of multiple sclerosis (MS). The goal is ...

Recruiting

Phase: PHASE3 Conditions: Multiple Sclerosis

Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study

NCT ID: NCT06958315

The INSPIRE Study is a clinical trial looking at a medication called inclisiran (Leqvio®) for patients with certain heart and blood vessel conditions, specifically atherosclerotic vascular disease ...

Recruiting

Conditions: Heterozygous Familial Hypercholesterolemia, Atherosclerotic Vascular Disease

Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

NCT ID: NCT06008756

The CORALreef study is a clinical trial that is looking at a new medication called enlicitide decanoate, which is an oral treatment designed to help lower cholesterol and reduce the risk of serious...

Recruiting

Phase: PHASE3 Conditions: Arteriosclerosis, Hypercholesterolaemia

Asciminib Roll-over Study

NCT ID: NCT04877522

The Asciminib Roll-over Study is a clinical trial designed to assess the long-term safety of a medication called asciminib for patients with chronic myelogenous leukemia (CML) who have previously p...

Recruiting

Phase: PHASE4 Conditions: Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

NCT ID: NCT06597019

This clinical trial is studying a medication called inclisiran to see how safe and effective it is for children aged 6 to under 12 years who have a condition known as heterozygous familial hypercho...

Recruiting

Phase: PHASE3 Conditions: Familial Hypercholesterolemia - Heterozygous

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

NCT ID: NCT05268289

This clinical trial is studying a new medication called iptacopan (also known as LNP023) for patients with active lupus nephritis, a condition where the immune system attacks the kidneys. The trial...

Recruiting

Phase: PHASE2 Conditions: Lupus Nephritis

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

NCT ID: NCT06717347

This clinical trial is studying a new treatment for patients with diffuse large B-cell lymphoma (DLBCL), a type of cancer that affects the lymphatic system. Researchers want to see if adding a drug...

Recruiting

Phase: PHASE3 Conditions: Diffuse Large B-Cell Lymphoma

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

NCT ID: NCT06492616

This clinical trial is studying a new medication called elacestrant to see how well it works compared to standard hormonal treatments in women and men with early-stage breast cancer that is hormone...

Recruiting

Phase: PHASE3 Conditions: Breast Cancer

Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain

NCT ID: NCT07013760

This clinical trial is looking to understand how effective a medication called tezepelumab is in treating patients with severe asthma in Spain. The study will gather information from patients who h...

Not yet recruiting

Conditions: Asthma

Secukinumab Open Label Roll-over Extension Protocol

NCT ID: NCT04638647

The Secukinumab Open Label Roll-over Extension Protocol is a clinical trial that aims to understand the long-term safety of a medication called secukinumab for people with autoimmune and inflammato...

Recruiting

Phase: PHASE4 Conditions: Autoimmunity, Inflammation

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

NCT ID: NCT05147220

This clinical trial is investigating the effectiveness and safety of a new medication called remibrutinib compared to an existing treatment, teriflunomide, for people with relapsing multiple sclero...

Recruiting

Phase: PHASE3 Conditions: Relapsing Multiple Sclerosis

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

NCT ID: NCT05156281

This clinical trial is studying the effectiveness and safety of a new treatment called remibrutinib compared to an existing drug, teriflunomide, in people with relapsing multiple sclerosis (RMS). R...

Recruiting

Phase: PHASE3 Conditions: Relapsing Multiple Sclerosis

Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)

NCT ID: NCT05653349

This clinical trial is studying a medication called ianalumab to see how well it works in helping adults with a condition called primary immune thrombocytopenia (ITP) maintain a healthy platelet co...

Recruiting

Phase: PHASE3 Conditions: Primary Immune Thrombocytopenia (ITP)

Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy

NCT ID: NCT06671938

This clinical trial is studying a new medication called exidavnemab to see if it's safe and well-tolerated in people with Parkinson's disease. The trial is currently recruiting participants aged 40...

Recruiting

Phase: PHASE2 Conditions: Parkinson Disease, Multiple System Atrophy

Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.

NCT ID: NCT06724159

The SOGUG-PRINCIS clinical trial is studying how effective certain new drugs are for treating genitourinary cancers, such as those affecting the kidney, bladder, or prostate. This is an observation...

Recruiting

Conditions: Genitourinary Cancers

Main Menu

Clinical Trials in Sevilla, Andalucia

33 Active Trials Found in Sevilla

FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study

Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

Asciminib Roll-over Study

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain

Secukinumab Open Label Roll-over Extension Protocol

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)

Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy

Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.